timothy sykes logo

Stock News

ONMD Soars as Strategic Alliances Drive Future Growth

Tim SykesAvatar
Written by Timothy Sykes Reviewed by Bryce Tuohey Fact-checked by Matt Monaco
Updated 10/11/2025, 9:19 am ET 10/11/2025, 9:19 am ET | 5 min 5 min read
ONMD Soars as Strategic Alliances Drive Future Growth Thumbnail

OneMedNet Corp’s stock surged 16.1% as market confidence soared following their breakthrough healthcare data integration announcement.

Healthcare industry expert:

Analyst sentiment – positive

Market Position & Fundamentals:
<> (ONMD) is currently in a precarious market position, characterized by exceedingly poor profitability metrics with an EBIT margin of -703% and a profit margin of -728.7%. The negative price-to-book ratio of -32.05 and a current ratio of 0.4 indicate financial distress. Moreover, revenue generation is weak, standing at $643,000 with operating cash flow reporting a deficit of $2.28 million, reflecting inefficacy in cash management and a reliance on external financing. Despite generating a net income of $2.98 million from continuing operations, this figure is overshadowed by troubling asset and equity positions, including negative stockholders’ equity of $3.84 million, suggesting sustainability concerns and the potential difficulty of future capital access.

Technical Analysis & Trading Strategy:
On a technical front, the weekly price chart showcases a recent bullish trend, marked by a significant increase from a low of $2.26 to a closing of $3.1, aided by a high-profile partnership announcement. An upward breakout above $2.82 resistance and a volume surge lend credibility to bullish momentum. Consequently, an actionable strategy would be to enter long positions as long as the price maintains above $2.82-$3.1 range with a cautious stop-loss slightly below the $2.48 support level, focusing on potential resistance at the next psychological threshold of $3.5-$3.75, aligning with the trend as long as it persists.

Catalysts & Outlook:
Recent strategic partnerships, notably with Palantir and Medcase, signify a potential turning point for ONMD, poised to diversify and bolster their AI-driven healthcare data analytics capabilities. Leveraging these alliances paves the way for tapping into high-growth segments within the healthcare sector. Market reaction, evidenced by a 132% surge in stock price post-partnership announcements, underscores investor optimism. While excitement surrounds these developments, it is crucial to note that sustained positive performance will rely on tangible revenue growth. Given the current market enthusiasm and strategic positioning, projection for ONMD remains cautiously optimistic, provided they leverage recent relationships effectively. Support is solidified at $2.82, with resistance targets around $3.75, pending market validation of these initiatives.

Candlestick Chart

Weekly Update Oct 06 – Oct 10, 2025: On Saturday, October 11, 2025 OneMedNet Corp stock [NASDAQ: ONMD] is trending up by 16.1%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

Looking at OneMedNet Corp’s recent stock performance, one can see dynamic fluctuations that signify robust market activity. Over the past few days, there has been a remarkable upswing in ONMD’s share prices, culminating in an impressive close at $3.10 on October 10, 2025. Such gains are reflective of strong market sentiment, buoyed by ONMD’s aggressive strategic alliances.

Financial reports tell another compelling story. The company posted a net income of $2.98M for the quarter ending June 2025, which is a notable achievement, especially given a challenging market environment. However, ONMD’s profit margins paint a tale of concern, showing negative figures across several indicators — an expected scene in the fast-evolving technology sector often fuelled by debt-financed expansion and heavy investment in R&D.

More Breaking News

Despite the daunting profitability hurdles, the overall revenue supported by newly forged partnerships hints at a substantial potential for future growth. Delving into key ratios, it becomes clear that ONMD’s current ratio stands at a challenging 0.4, pointing to liquidity constraints. Furthermore, the high leverage, as noted in the price-to-sales ratio of 267.56, reveals aggressive investments in innovation and platform development in the rapidly-growing healthcare AI landscape.

Conclusion

In conclusion, ONMD is deftly navigating the healthcare sector through strategic foresight and collaborations that emphasize growth and innovation. Despite some internal financial weaknesses, such as negative profit margins and liquidity issues, the recent stock surge suggests that traders are willing to bet on ONMD’s potential and strategic direction. As millionaire penny stock trader and teacher Tim Sykes, says, “It’s better to go home at zero than to go home in the red.” This mindset reflects the traders’ optimism about ONMD’s strategic moves, balancing the risks of financial loss with the promise of future gains. Moving forward, maintaining momentum will require converting these strategic partnerships into tangible business results without letting profitability concerns overshadow growth prospects. The journey may be fraught with challenges, but with the backing of major players like Palantir, ONMD appears poised to capture new heights in the AI-driven healthcare market.

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:

How much has this post helped you?

(0 votes, average: 0 out of 5)
Leave a reply
Author card Timothy Sykes picture

Tim Sykes

Head Writer at TimothySykes.com, Lead Mentor at the Trading Challenge
In his 20-plus years of trading, Tim has made $7.9 million. In his 15-plus years of teaching, Tim’s Trading Challenge has produced over 30 millionaire students. His philosophy emphasizes small gains and cutting losses quickly.
Read More

* Results are not typical and will vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk. See Terms of Service here

The available research on day trading suggests that most active traders lose money. Fees and overtrading are major contributors to these losses.

A 2000 study called “Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors” evaluated 66,465 U.S. households that held stocks from 1991 to 1996. The households that traded most averaged an 11.4% annual return during a period where the overall market gained 17.9%. These lower returns were attributed to overconfidence.

A 2014 paper (revised 2019) titled “Learning Fast or Slow?” analyzed the complete transaction history of the Taiwan Stock Exchange between 1992 and 2006. It looked at the ongoing performance of day traders in this sample, and found that 97% of day traders can expect to lose money from trading, and more than 90% of all day trading volume can be traced to investors who predictably lose money. Additionally, it tied the behavior of gamblers and drivers who get more speeding tickets to overtrading, and cited studies showing that legalized gambling has an inverse effect on trading volume.

A 2019 research study (revised 2020) called “Day Trading for a Living?” observed 19,646 Brazilian futures contract traders who started day trading from 2013 to 2015, and recorded two years of their trading activity. The study authors found that 97% of traders with more than 300 days actively trading lost money, and only 1.1% earned more than the Brazilian minimum wage ($16 USD per day). They hypothesized that the greater returns shown in previous studies did not differentiate between frequent day traders and those who traded rarely, and that more frequent trading activity decreases the chance of profitability.

These studies show the wide variance of the available data on day trading profitability. One thing that seems clear from the research is that most day traders lose money .

Millionaire Media 66 W Flagler St. Ste. 900 Miami, FL 33130 United States (888) 878-3621 This is for information purposes only as Millionaire Media LLC nor Timothy Sykes is registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. Millionaire Media LLC and Timothy Sykes cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. Millionaire Media LLC and Timothy Sykes in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, Millionaire Media LLC and Timothy Sykes accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, nor should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns.

Citations for Disclaimer

Barber, Brad M. and Odean, Terrance, Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors. Available at SSRN: “Day Trading for a Living?”

Barber, Brad M. and Lee, Yi-Tsung and Liu, Yu-Jane and Odean, Terrance and Zhang, Ke, Learning Fast or Slow? (May 28, 2019). Forthcoming: Review of Asset Pricing Studies, Available at SSRN: “https://ssrn.com/abstract=2535636”

Chague, Fernando and De-Losso, Rodrigo and Giovannetti, Bruno, Day Trading for a Living? (June 11, 2020). Available at SSRN: “https://ssrn.com/abstract=3423101”